Advertisement

Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?

  • M.I. Garvey
    Correspondence
    Corresponding author. Address: Infection Prevention and Control Team, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, B15 2WB, UK. Tel.: +44 (0)121 371 3787.
    Affiliations
    Infection Prevention and Control Team, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK
    Search for articles by this author
  • C.W. Bradley
    Affiliations
    Infection Prevention and Control Team, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK
    Search for articles by this author
  • M.J. Biggs
    Affiliations
    Infection Prevention and Control Team, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK
    Search for articles by this author
  • E. Holden
    Affiliations
    Infection Prevention and Control Team, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK
    Search for articles by this author
  • M.J. Gill
    Affiliations
    Infection Prevention and Control Team, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK
    Search for articles by this author
Published:November 07, 2017DOI:https://doi.org/10.1016/j.jhin.2017.10.023
      The importance of Pseudomonas aeruginosa in healthcare settings is well described in the literature, and is covered by a Health Technical Memorandum (HTM 04-01) [
      • Walker J.
      • Moore G.
      Safe water in healthcare premises.
      ,
      • Garvey M.I.
      • Bradley C.W.
      • Tracey J.
      • Oppenheim B.
      Continued transmission of Pseudomonas aeruginosa from a hand wash basin tap in a critical care unit.
      ,
      • Department of Health
      Health Technical Memorandum 04–01: safe water in healthcare premises. Part C: Pseudomonas aeruginosa – advice for augmented care units.
      ]. P. aeruginosa infections on haematology wards occur frequently and transmission from hospital water sources is recognized [
      • Richet H.
      • Escande M.C.
      • Marie J.P.
      • Zittoun R.
      • Lagrange P.H.
      Epidemic Pseudomonas aeruginosa serotype O16 bacteraemia in haematology-oncology patient.
      ]. Here, we demonstrate transmission of P. aeruginosa from water to patients in a haematology setting at the University Hospitals Birmingham (UHB) NHS Foundation Trust. We also examine the association between antimicrobial usage and meropenem-resistant P. aeruginosa bloodstream infections (BSIs).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Walker J.
        • Moore G.
        Safe water in healthcare premises.
        J Hosp Infect. 2016; 94: 1
        • Garvey M.I.
        • Bradley C.W.
        • Tracey J.
        • Oppenheim B.
        Continued transmission of Pseudomonas aeruginosa from a hand wash basin tap in a critical care unit.
        J Hosp Infect. 2016; 94: 8-12
        • Department of Health
        Health Technical Memorandum 04–01: safe water in healthcare premises. Part C: Pseudomonas aeruginosa – advice for augmented care units.
        2016 (Available at:)
        • Richet H.
        • Escande M.C.
        • Marie J.P.
        • Zittoun R.
        • Lagrange P.H.
        Epidemic Pseudomonas aeruginosa serotype O16 bacteraemia in haematology-oncology patient.
        J Clin Microbiol. 1989; 27: 1992-1996
        • Garvey M.I.
        • Bradley C.W.
        • Holden E.
        • Weinbren M.
        Where to do water testing for Pseudomonas aeruginosa in a healthcare setting.
        J Hosp Infect. 2017; 97: 192-195
        • Kaufmann M.E.
        Pulsed-field gel electrophoresis.
        in: Woodford N. Johnson A.P. Methods in molecular medicine. 15: molecular bacteriology: protocols and clinical applications. Humana Press, Totowa, NJ1998: 33-50
        • Public Health England
        UK standards for microbiology investigation – B37. Investigation of blood cultures (for organisms other than Mycobacterium species).
        2016 (Available at:)
      1. British Society for Antimicrobial Chemotherapy (BSAC). Susceptibility testing methodology. Available at: http://www.bsac.org.uk/stewardship-surveillance/susceptibility/methodologylatestversion/ [last accessed October 2017].

      2. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints, antimicrobial susceptibility testing. Available at: http://www.eucast.org/clinical_breakpoints/ [last accessed October 2017].

      3. World Health Organization Collaborating Centre for Drug Statistics Methodology. Defined daily doses definition and methodology. Available at: https://www.whocc.no/ddd/definition_and_general_considera/ [last accessed October 2017].

        • McCarthy K.L.
        • Paterson D.L.
        Long-term mortality following Pseudomonas aeruginosa bloodstream infection.
        J Hosp Infect. 2017; 95: 292-299
        • Garvey M.I.
        • Bradley C.W.
        • Holden E.
        Waterborne Pseudomonas aeruginosa transmission in a haematology unit?.
        Am J Infect Control. 2017; 220: 1014-1019
        • Public Health England
        Antimicrobial resistance local indicators.
        2017 (Available at:)